Staphylococcus aureus Colonization: Duration, Risks, and Decolonization

Staphylococcus aureus asymptomatically colonizes the anterior nares (nose), skin (perineum, axilla), and throat in 20–30% of healthy adults (persistent carriers), 30–50% intermittently, and 20–30% non-carriers.

Colonization vs. Infection

  • Colonization: Bacteria present without tissue invasion or immune response. Can persist for months to years.
  • Infection: Invasion → inflammation, pus, tissue damage (abscess, cellulitis, bacteremia, pneumonia, endocarditis, SSI).

Risk Factors for Progression to Infection

  • Breach of skin barrier (surgery, trauma, IV catheter, dialysis, burns, eczema).
  • Immunosuppression (diabetes, HIV, chemo, steroids, biologics).
  • Healthcare exposure (hospitalization, long-term care).
  • Strain virulence (PVL-positive, MRSA).

Decolonization (When Indicated)

  • Pre-operative (orthopedic, cardiac, neurosurgery) – reduces SSI.
  • Recurrent SSTI (skin/soft tissue infections) in household.
  • Outbreak control.

Regimen: Intranasal mupirocin 2% BID × 5 days + chlorhexidine 4% body wash daily × 5 days. Household contacts may be treated simultaneously.

Key Points

  • Colonization is common and not an infection.
  • It is a reservoir for autoinfection and transmission.
  • Routine decolonization of all carriers is not recommended (resistance risk, microbiome disruption).
  • MRSA colonization follows same principles; use mupirocin only if susceptible.

Huna Hypnotherapy - Related Articles